These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22770978)

  • 1. The inside and out of dystroglycan post-translational modification.
    Moore CJ; Winder SJ
    Neuromuscul Disord; 2012 Nov; 22(11):959-65. PubMed ID: 22770978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
    Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
    Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.
    Hara Y; Kanagawa M; Kunz S; Yoshida-Moriguchi T; Satz JS; Kobayashi YM; Zhu Z; Burden SJ; Oldstone MB; Campbell KP
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17426-31. PubMed ID: 21987822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.
    Kanagawa M; Michele DE; Satz JS; Barresi R; Kusano H; Sasaki T; Timpl R; Henry MD; Campbell KP
    FEBS Lett; 2005 Aug; 579(21):4792-6. PubMed ID: 16098969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcospan increases laminin-binding capacity of α-dystroglycan to ameliorate DMD independent of Galgt2.
    Mamsa H; Stark RL; Shin KM; Beedle AM; Crosbie RH
    Hum Mol Genet; 2022 Mar; 31(5):718-732. PubMed ID: 34581784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
    Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
    Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro developmental expression of dystroglycan and laminin-alpha2 in human skeletal muscle.
    Chen L; Burgunder JM
    Cell Biol Int; 2005 Jul; 29(7):506-13. PubMed ID: 15982904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.
    de Bernabé DB; Inamori K; Yoshida-Moriguchi T; Weydert CJ; Harper HA; Willer T; Henry MD; Campbell KP
    J Biol Chem; 2009 Apr; 284(17):11279-84. PubMed ID: 19244252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
    Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
    J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE.
    Inamori K; Yoshida-Moriguchi T; Hara Y; Anderson ME; Yu L; Campbell KP
    Science; 2012 Jan; 335(6064):93-6. PubMed ID: 22223806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
    Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
    Elife; 2023 Feb; 12():. PubMed ID: 36723429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies.
    Gumlaw N; Sevigny LM; Zhao H; Luo Z; Bangari DS; Masterjohn E; Chen Y; McDonald B; Magnay M; Travaline T; Yoshida-Moriguchi T; Fan W; Reczek D; Stefano JE; Qiu H; Beil C; Lange C; Rao E; Lukason M; Barry E; Brondyk WH; Zhu Y; Cheng SH
    Mol Ther; 2020 Feb; 28(2):664-676. PubMed ID: 31843448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezrin-dependent regulation of the actin cytoskeleton by beta-dystroglycan.
    Spence HJ; Chen YJ; Batchelor CL; Higginson JR; Suila H; Carpen O; Winder SJ
    Hum Mol Genet; 2004 Aug; 13(15):1657-68. PubMed ID: 15175275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.
    Kuga A; Kanagawa M; Sudo A; Chan YM; Tajiri M; Manya H; Kikkawa Y; Nomizu M; Kobayashi K; Endo T; Lu QL; Wada Y; Toda T
    J Biol Chem; 2012 Mar; 287(12):9560-7. PubMed ID: 22270369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystroglycan glycosylation and muscular dystrophy.
    Moore CJ; Hewitt JE
    Glycoconj J; 2009 Apr; 26(3):349-57. PubMed ID: 18773291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle dystroglycan organizes the postsynapse and regulates presynaptic neurotransmitter release at the Drosophila neuromuscular junction.
    Bogdanik L; Framery B; Frölich A; Franco B; Mornet D; Bockaert J; Sigrist SJ; Grau Y; Parmentier ML
    PLoS One; 2008 Apr; 3(4):e2084. PubMed ID: 18446215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the functions of LARGE: lessons from mutant mice.
    Hewitt JE
    Methods Enzymol; 2010; 479():367-86. PubMed ID: 20816177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role of dystroglycan in schwannoma cell adhesion to laminin.
    Matsumura K; Chiba A; Yamada H; Fukuta-Ohi H; Fujita S; Endo T; Kobata A; Anderson LV; Kanazawa I; Campbell KP; Shimizu T
    J Biol Chem; 1997 May; 272(21):13904-10. PubMed ID: 9153251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal glycosylation of dystroglycan in human genetic disease.
    Hewitt JE
    Biochim Biophys Acta; 2009 Sep; 1792(9):853-61. PubMed ID: 19539754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
    Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
    Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.